![Julie Daves](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Julie VanOrsdel Daves formerly worked at miRagen Therapeutics, Inc., as Senior Director-Clinical Operations from 2016 to 2018, Chiltern International, Inc., as Global Head & Senior Director-Clinical from 2015 to 2016, BioCryst Pharmaceuticals, Inc., as Senior Manager-Clinical Development from 2007 to 2011, Sanifit Therapeutics SA, as Vice President & Global Head-Clinical Operations from 2021 to 2022, Edgewise Therapeutics, Inc., as Vice President-Outsourcing & Vendor Management in 2021, and DiaMedica Therapeutics, Inc., as Senior VP-Clinical Development Operations from 2022 to 2024.
Ms. Daves received her undergraduate degree from North Carolina State University and graduate degree from George Washington University School of Medicine & Health.
Eerdere bekende functies van Julie Daves
| Bedrijven | Functie | Einde |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Corporate Officer/Principal | 18-04-2024 |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Corporate Officer/Principal | 01-08-2022 |
| EDGEWISE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-08-2021 |
miRagen Therapeutics, Inc. /Old/
 miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops microRNA-based therapeutics for cardiovascular and muscle diseases | Corporate Officer/Principal | 01-02-2018 |
Chiltern International, Inc.
 Chiltern International, Inc. BiotechnologyHealth Technology Operates as a contract research organization which provides clinical development, scientific services and collaborative technologies | Corporate Officer/Principal | 01-02-2016 |
Opleiding van Julie Daves
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
28
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
miRagen Therapeutics, Inc. /Old/
miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops microRNA-based therapeutics for cardiovascular and muscle diseases | Health Technology |
North Carolina State University
 North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Health Technology |
Chiltern International, Inc.
Chiltern International, Inc. BiotechnologyHealth Technology Operates as a contract research organization which provides clinical development, scientific services and collaborative technologies | Health Technology |
George Washington University School of Medicine & Health
 George Washington University School of Medicine & Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edgewise Therapeutics, Inc.
 Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
